Your browser doesn't support javascript.
loading
Prediction of Relapse After Anti-Tumor Necrosis Factor Cessation in Crohn's Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies.
Pauwels, Renske W M; van der Woude, C Janneke; Nieboer, Daan; Steyerberg, Ewout W; Casanova, María J; Gisbert, Javier P; Kennedy, Nick A; Lees, Charlie W; Louis, Edouard; Molnár, Tamás; Szántó, Kata; Leo, Eduardo; Bots, Steven; Downey, Robert; Lukas, Milan; Lin, Wei C; Amiot, Aurelien; Lu, Cathy; Roblin, Xavier; Farkas, Klaudia; Seidelin, Jakob B; Duijvestein, Marjolijn; D'Haens, Geert R; de Vries, Annemarie C.
Afiliação
  • Pauwels RWM; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van der Woude CJ; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Nieboer D; Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Steyerberg EW; Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.
  • Casanova MJ; Department of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa, Universidad Autónoma de Madrid, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain.
  • Gisbert JP; Department of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa, Universidad Autónoma de Madrid, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain.
  • Kennedy NA; Exeter Inflammatory Bowel Disease Research Group, University of Exeter, Exeter, United Kingdom; Department of Gastroenterology and Hepatology, Western General Hospital, Edinburgh, United Kingdom.
  • Lees CW; Department of Gastroenterology and Hepatology, Western General Hospital, Edinburgh, United Kingdom.
  • Louis E; Department of Gastroenterology and Hepatology, Centre Hospitalier Universitaire de Liège, Liège, Belgium.
  • Molnár T; First Department of Medicine, University of Szeged, Szeged, Hungary.
  • Szántó K; First Department of Medicine, University of Szeged, Szeged, Hungary.
  • Leo E; Department of Digestive Diseases, Hospital Universitario Virgen del Rocío, Seville, Spain.
  • Bots S; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Academic Medical Centre, Amsterdam, The Netherlands.
  • Downey R; Department of Gastroenterology and Hepatology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals, National Health Service Foundation Trust, Sheffield, United Kingdom.
  • Lukas M; Inflammatory Bowel Disease Clinical and Research Centre, Iscare a.s, Prague, Czech Republic; Institute of Medical Biochemistry and Laboratory Diagnostics, First Medical Faculty, General Teaching Hospital, Prague, Czech Republic.
  • Lin WC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan.
  • Amiot A; Department of Gastroenterology, Assistance Publique-Hôpitaux de Paris, Paris Est Creteil University, Henri Mondor Hospital, Paris Est Creteil University; Department of Gastroenterology, Paris Est-Créteil Val de Marne University, Assistance Publique-Hôpitaux de Paris, Henri Mondor Hospital, Creteil,
  • Lu C; Division of Gastroenterology, Zeidler Ledcor Center, University of Alberta, Edmonton, Alberta, Canada; Division of Gastroenterology, Calgary, Alberta, Canada.
  • Roblin X; Department of Gastro-Enterology, INSERM CIC 1408, Paris, France; Department of Gastroenterology, University of Saint Etienne, Centre Hospitalier Universitaire Hopital Nord, Saint Etienne, France.
  • Farkas K; First Department of Medicine, University of Szeged, Szeged, Hungary.
  • Seidelin JB; Department of Gastroenterology, Herlev Hospital, Herlev, Denmark.
  • Duijvestein M; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • D'Haens GR; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • de Vries AC; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: a.c.devries@erasmusmc.nl.
Clin Gastroenterol Hepatol ; 20(8): 1671-1686.e16, 2022 08.
Article em En | MEDLINE | ID: mdl-33933376
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Crohn / Inibidores do Fator de Necrose Tumoral Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Crohn / Inibidores do Fator de Necrose Tumoral Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article